Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Raytheon Technologies Corp (RTX) vs 10X Genomics Inc (TXG) Price & Performance

Raytheon Technologies CorpTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Raytheon Technologies Corp vs 10X Genomics Inc — how do they compare? Raytheon Technologies Corp trades at $193.75 (market cap $261.85B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Raytheon Technologies Corp is far larger — about 47.8× 10X Genomics Inc's market cap, and Raytheon Technologies Corp pays a 1.5% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.

RTXTXG
Market Cap
$261.85B$5.48B
Sector
IndustrialsHealth
52-Week High
$212.16$45.80
52-Week Low
$149.17$11.34
Enterprise Value
$293.97B$5.02B
Dividend Yield
1.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Raytheon Technologies Corp

RTX trades at $193.51, down 0.44% today, with a bullish technical signal and strong analyst support. Recent contract wins, including a $515 million Navy radar deal (PRNewsWire, June 3, 2026), and earnings beats in Q4 2025 and Q1 2026 highlight operational momentum. Revenue growth accelerated to $88.6 billion in 2025, with net income margin improving to 8.03%. The stock faces resistance near $196-$199, with support at $192.

The outlook remains positive given defense spending tailwinds and production expansions, but elevated P/E of 36.48 poses valuation risk. Analysts project 10% upside to a $213 consensus target, with no sell ratings. Key risks include debt levels and geopolitical volatility affecting contracts.

10X Genomics Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Raytheon Technologies Corp

Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.

Read more on RTX

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG